Figure 4.
Relationship between versican and FEV1. Relationship between versican immuno-staining intensities for alveolar wall (a) and alveolar rims (b) and FEV1% in control (closed circles) and COPD (open circles) patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.